Biotech startup Arnatar raises $50m Series A round to build China presence
Founded in 2022, Arnatar specialises in antisense drug discovery and development.
Stay updated with breaking news from Transfar Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Founded in 2022, Arnatar specialises in antisense drug discovery and development.
The credit-scoring company appears to be headed for official approval to begin operations after a wait of more than two years, with the People’s Bank of China guiding its application, official says.
THE National Development and Reform Commission (NDRC), China's top economic planner, held its third meeting in a month with private company representatives on Monday to learn about their business situation and operating difficulties, vowing to address their concerns.
Business Closeup: A 37-yr-old Chinese firm seeks to reinvent itself with innovation-
More efforts are needed from private companies to drive digital transformation to boost the resilience of supply and industrial chains for higher-quality development, said the country's lawmakers during the annual two sessions.